Gilead to buy MYR for about €1.15B

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Gilead Sciences announced that it will buy MYR for about €1.15B in cash, providing an access to the German biotech firm's treatment for a viral hepatitis.
Back to articles

Actual Topics

Thu, 10 Dec 2020 20:45:19 GMT

BP expands deal with Amazon

Oil major BP broadened its renewable energy supply agreement with Amazon.com to power Amazon Web Services and the US e-commerce company's operations in Europe.

Fri, 11 Dec 2020 01:08:35 GMT

US weekly unemployment claims rise

The number of US jobless claims surged to almost three-month high the previous week, after rising new COVID-19 cases resulted in more business restrictions, the Labor Department reported.

Subscribe to "Fundamental Analysis" feed

Souscrire
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.